Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease.

Literature DB >> 12899148

S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease.

M L Hardy, I Coulter, S C Morton, J Favreau, S Venuturupalli, F Chiappelli, F Rossi, G Orshansky, L K Jungvig, E A Roth, M J Suttorp, P Shekelle.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
S-Adenosylmethionine

Year: 2003 PMID： 12899148 PMCID： PMC4781303

Source DB: PubMed Journal: Evid Rep Technol Assess (Summ) ISSN： 1530-440X

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

Review 1. Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.

Authors: Mazen Noureddin; José M Mato; Shelly C Lu
Journal: Exp Biol Med (Maywood) Date: 2015-04-13

2. Neonatal maternal separation stress elicits lasting DNA methylation changes in the hippocampus of stress-reactive Wistar Kyoto rats.

Authors: Chelsea R McCoy; Samir Rana; Sara Anne Stringfellow; Jeremy J Day; J Michael Wyss; Sarah M Clinton; Ilan A Kerman
Journal: Eur J Neurosci Date: 2016-10-16 Impact factor: 3.386

Review 3. DNA demethylation and invasive cancer: implications for therapeutics.

Authors: David Cheishvili; Lisa Boureau; Moshe Szyf
Journal: Br J Pharmacol Date: 2015-04-27 Impact factor: 8.739

4. Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder.

Authors: Hitoshi Sakurai; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price; George I Papakostas; Christina M Dording; Albert S Yeung; Cristina Cusin; Elizabeth Ludington; Richard Bernard-Negron; Maurizio Fava; David Mischoulon
Journal: J Affect Disord Date: 2019-10-31 Impact factor: 4.839

5. Genetic predisposition to high anxiety- and depression-like behavior coincides with diminished DNA methylation in the adult rat amygdala.

Authors: Chelsea R McCoy; Nateka L Jackson; Jeremy Day; Sarah M Clinton
Journal: Behav Brain Res Date: 2016-12-11 Impact factor: 3.332

S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease.

Review 1. Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.

2. Neonatal maternal separation stress elicits lasting DNA methylation changes in the hippocampus of stress-reactive Wistar Kyoto rats.

Review 3. DNA demethylation and invasive cancer: implications for therapeutics.

4. Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder.

5. Genetic predisposition to high anxiety- and depression-like behavior coincides with diminished DNA methylation in the adult rat amygdala.

6. S-adenosyl-L-methionine (SAMe) for smoking abstinence: a randomized clinical trial.

Review 7. S-adenosylmethionine in liver health, injury, and cancer.

Review 8. Complementary and alternative medicine therapies to promote healthy moods.

9. Phase II evaluation of S-adenosyl-L-methionine (SAMe) for the treatment of hot flashes.

Review 10. S-adenosyl methionine (SAMe) for depression in adults.